Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’

David Gibson, senior associate at McDermott Will & Emery

Why did you decide to specialise in life sciences law, and what’s the best thing about being a life sciences lawyer?

Your limit of 1 article in 30 days is up. Please login for full access or subscribe.

Corporate users - click here for simple access (no password needed).

For more information, please contact jasmine.glass@legalbusiness.co.uk